Phase 2 clinical trial for CLAR-121 for the treatment of periductal mastitis
Latest Information Update: 16 May 2022
At a glance
- Drugs Anastrozole/testosterone (Primary)
- Indications Mastitis
- Focus Therapeutic Use
Most Recent Events
- 16 May 2022 New trial record
- 10 May 2022 According to a Clarus Therapeutics media release, the company expect to initiate this trial in the second half of 2022, subject to the availability of funding.